Results 1 to 10 of about 2,289,660 (191)

Transcatheter Tricuspid Valve Intervention: Current Perspective [PDF]

US Cardiology Review, 2021
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects.
Trevor J Simard, Mackram F Eleid
doaj   +6 more sources

Transcatheter Tricuspid Valve Intervention: Coaptation Devices [PDF]

Frontiers in Cardiovascular Medicine, 2020
Transcatheter tricuspid valve intervention (TTVI) has recently emerged as an alternative for the treatment of severe tricuspid regurgitation (TR). Multiple percutaneous devices have been developed in the last decade with promising early results.
Guillem Muntané-Carol, Alberto Alperi, Laurent Faroux, Elisabeth Bédard, François Philippon, Josep Rodés-Cabau   +5 more
doaj   +5 more sources

Exploration of Anesthetic Strategies for Transcatheter Tricuspid Valve Intervention [PDF]

Reviews in Cardiovascular Medicine
Tricuspid regurgitation (TR) is a critical factor in the progression of right heart failure. Although conventional open surgery remains the definitive treatment, the application of this technique is significantly limited in older and high-risk patients ...
Shuantong Lin, Yulong Guan
doaj   +5 more sources

Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late [PDF]

Structural Heart
Tricuspid regurgitation (TR) is a common but frequently underrecognized condition associated with substantial morbidity and mortality. Long regarded as a mere bystander of left-sided heart disease, TR was often left untreated, contributing to late ...
Jennifer von Stein, MD, Philipp von Stein, MD, Maria C. Alu, MS, Andrea Scotti, MD, Edwin C. Ho, MD, Juan F. Granada, MD, Azeem Latib, MD   +6 more
doaj   +2 more sources

Single-Session Transcatheter Aortic and Tricuspid Valve-in-Valve Implantation in a Patient with Prior Multivalve Surgery and a Chronic Transvenous Pacing Lead: A Case-Based Review of Procedural Strategy [PDF]

Life
Background: The population of patients surviving previous multivalve surgery is expanding, and structural Heart Teams increasingly encounter complex multivalvular disease requiring reintervention, for which redo surgery carries prohibitive risk.
Cristian Mornoș, Laurentiu Pașcalau, Vlad Anton Iliescu, Aniko Mornoș, Daniel-Miron Brie, Horea Feier, Mihai-Andrei Lazăr, Silvius-Alexandru Pescariu, Dragoș Cozma   +8 more
doaj   +2 more sources

Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR).
Wang Wei, Li Ning, Li Ning, Ning Xiaoping, Xu Zhiyun, Li Bailing, Cai Chengliang, Yang Fan, Zhou Guangwei, Bai Yifan, Han Lin, Qiao Fan, Lu Fanglin   +12 more
doaj   +3 more sources

The right ventricle as the Achilles' heel: tricuspid regurgitation and right heart failure in the era of mechanical circulatory support [PDF]

Frontiers in Cardiovascular Medicine
Across the mechanical circulatory support (MCS) spectrum, from temporary devices in acute cardiogenic shock to durable left ventricular assist devices, the right ventricle (RV) and tricuspid valve are often underestimated determinants of outcome.
Wentao Wu, Shuohao Wang, Gaojun Xu, Fengjuan Liu, Zhenghe Liu, Xuan Wu, Xia Gao, Zhenwei Ge   +7 more
doaj   +2 more sources

Simplified Outcome Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention by Survival Tree-Based Modelling [PDF]

JACC: Advances
Background: Patients with severe tricuspid regurgitation (TR) typically present with heterogeneity in the extent of cardiac dysfunction and extra-cardiac comorbidities, which play a decisive role for survival after transcatheter tricuspid valve ...
Vera Fortmeier, MD, Mark Lachmann, MD, Lukas Stolz, MD, Jennifer von Stein, MD, Karl-Philipp Rommel, MD, Mohammad Kassar, MD, Muhammed Gerçek, MD, Anne R. Schöber, MD, Thomas J. Stocker, MD, Hazem Omran, MD, Michelle Fett, Jule Tervooren, Maria I. Körber, MD, Amelie Hesse, Gerhard Harmsen, PhD, Kai Peter Friedrichs, MD, Shinsuke Yuasa, MD, PhD, Tanja K. Rudolph, MD, Michael Joner, MD, Roman Pfister, MD, Stephan Baldus, MD, Karl-Ludwig Laugwitz, MD, Stephan Windecker, MD, Fabien Praz, MD, Philipp Lurz, MD, Jörg Hausleiter, MD, Volker Rudolph, MD   +26 more
doaj   +2 more sources

Rapid Native and Bioprosthetic Tricuspid Valve Degeneration in Carcinoid Heart Disease [PDF]

JACC: Case Reports
Background: Carcinoid heart disease (CaHD) is a severe complication of metastatic neuroendocrine tumors characterized by serotonin-mediated fibrotic degeneration of right-sided cardiac valves.
Lucia Trabucchi, MS, Richiele Forgiarini, MD, Maria I. Ardid, MD, Abraham Abdemur, MD, Raul E. Herrera, MD, Rodolfo Arce, MD, Tom C. Nguyen, MD, Ramon Quesada, MD, Elliott J. Elias, MD, Nish Patel, MD   +9 more
doaj   +2 more sources

Persistent Severe Tricuspid Regurgitation After Mitral Transcatheter Edge-to-Edge Repair: Prognostic Implications of Guideline-Based Eligibility for Transcatheter Tricuspid Valve Intervention [PDF]

Structural Heart
Background: Persistent tricuspid regurgitation (TR) after mitral transcatheter edge-to-edge repair (M-TEER) is common and associated with adverse outcomes.
Moritz Kühlein, MD, Jule Tervooren, Vera Fortmeier, MD, Amelie Hesse, Elena Rippen, MD, Michelle Fett, Héctor Alfonso Alvarez Covarrubias, MD, Moritz von Scheidt, MD, Ferdinand Roski, Muhammed Gerçek, MD, Shinsuke Yuasa, MD, PhD, N. Patrick Mayr, MD, Erion Xhepa, MD, PhD, Karl-Ludwig Laugwitz, MD, Michael Joner, MD, Volker Rudolph, MD, Teresa Trenkwalder, MD, Tobias Rheude, MD, Mark Lachmann, MD   +18 more
doaj   +2 more sources